Allen Investment Management LLC Boosts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Allen Investment Management LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,024,637 shares of the healthcare conglomerate’s stock after purchasing an additional 167,240 shares during the period. UnitedHealth Group accounts for approximately 6.3% of Allen Investment Management LLC’s holdings, making the stock its 6th biggest position. Allen Investment Management LLC’s holdings in UnitedHealth Group were worth $521,807,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in UNH. Macroview Investment Management LLC raised its holdings in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. Delos Wealth Advisors LLC boosted its stake in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares in the last quarter. True Wealth Design LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $31,000. Bbjs Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $31,000. Finally, Signature Resources Capital Management LLC boosted its holdings in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on UNH. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, September 9th. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Royal Bank of Canada upped their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Truist Financial increased their target price on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Morgan Stanley upped their price target on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $593.99 on Friday. The company has a market cap of $548.50 billion, a P/E ratio of 36.31, a P/E/G ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The business’s 50 day moving average is $569.08 and its two-hundred day moving average is $517.54. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the company earned $6.14 earnings per share. The firm’s revenue was up 6.4% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.